Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

December 03, 2009

IN RE: BUDEPRION XL MARKETING & SALES PRACTICES LITIGATION

Track this case

Case Number:

2:09-md-02107

Court:

Pennsylvania Eastern

Nature of Suit:

Fraud or Truth-In-Lending

Multi Party Litigation:

Multi-district Litigation

Judge:

BERLE M. SCHILLER

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. February 03, 2012

    Impax, Teva Put Generic-Wellbutrin MDL To Bed

    A Pennsylvania federal judge on Wednesday granted preliminary approval for the settlement of multidistrict consumer fraud litigation claiming Impax Laboratories Inc.'s generic version of the antidepressant Wellbutrin XL was deceptively labeled and is less effective and more dangerous than the brand-name pill.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login